Betta Pharmaceuticals Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 16.57% vs -9.52% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 1,476.19% vs -109.75% in Dec 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,039.80",
          "val2": "892.00",
          "chgp": "16.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "290.50",
          "val2": "199.60",
          "chgp": "45.54%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.00",
          "val2": "18.60",
          "chgp": "-3.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "24.30",
          "val2": "-10.70",
          "chgp": "327.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "231.20",
          "val2": "-16.80",
          "chgp": "1,476.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "279.40%",
          "val2": "67.00%",
          "chgp": "21.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 24.70% vs 17.80% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -26.05% vs 16.01% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,596.40",
          "val2": "2,884.00",
          "chgp": "24.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,090.70",
          "val2": "848.00",
          "chgp": "28.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "77.70",
          "val2": "46.90",
          "chgp": "65.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-58.70",
          "val2": "-53.80",
          "chgp": "-9.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "286.20",
          "val2": "387.00",
          "chgp": "-26.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "150.10%",
          "val2": "165.10%",
          "chgp": "-1.50%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

1,039.80

892.00

16.57%

Operating Profit (PBDIT) excl Other Income

290.50

199.60

45.54%

Interest

18.00

18.60

-3.23%

Exceptional Items

24.30

-10.70

327.10%

Consolidate Net Profit

231.20

-16.80

1,476.19%

Operating Profit Margin (Excl OI)

279.40%

67.00%

21.24%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 16.57% vs -9.52% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 1,476.19% vs -109.75% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,596.40

2,884.00

24.70%

Operating Profit (PBDIT) excl Other Income

1,090.70

848.00

28.62%

Interest

77.70

46.90

65.67%

Exceptional Items

-58.70

-53.80

-9.11%

Consolidate Net Profit

286.20

387.00

-26.05%

Operating Profit Margin (Excl OI)

150.10%

165.10%

-1.50%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 24.70% vs 17.80% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -26.05% vs 16.01% in Dec 2024

All Annual Results